CRX Expression in Pluripotent Stem Cell-Derived Photoreceptors Marks a Transplantable Subpopulation of Early Cones.


Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
05 2019
Historique:
received: 23 06 2018
revised: 05 11 2018
accepted: 03 12 2018
pubmed: 27 1 2019
medline: 28 4 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

Death of photoreceptors is a common cause of age-related and inherited retinal dystrophies, and thus their replenishment from renewable stem cell sources is a highly desirable therapeutic goal. Human pluripotent stem cells provide a useful cell source in view of their limitless self-renewal capacity and potential to not only differentiate into cells of the retina but also self-organize into tissue with structure akin to the human retina as part of three-dimensional retinal organoids. Photoreceptor precursors have been isolated from differentiating human pluripotent stem cells through application of cell surface markers or fluorescent reporter approaches and shown to have a similar transcriptome to fetal photoreceptors. In this study, we investigated the transcriptional profile of CRX-expressing photoreceptor precursors derived from human pluripotent stem cells and their engraftment capacity in an animal model of retinitis pigmentosa (Pde6brd1), which is characterized by rapid photoreceptor degeneration. Single cell RNA-Seq analysis revealed the presence of a dominant cell cluster comprising 72% of the cells, which displayed the hallmarks of early cone photoreceptor expression. When transplanted subretinally into the Pde6brd1 mice, the CRX

Identifiants

pubmed: 30681766
doi: 10.1002/stem.2974
pmc: PMC6519156
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-622

Subventions

Organisme : Medical Research Council
ID : MR/N015037/1
Pays : United Kingdom
Organisme : MRC
ID : MC_PC_15030
Pays : International
Organisme : Medical Research Council
ID : MC_UP_1501/2
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/C016106/1
Pays : United Kingdom
Organisme : MRC
ID : MR/M008886/1
Pays : International
Organisme : Medical Research Council
ID : MC_PC_15030
Pays : United Kingdom
Organisme : BBSRC
ID : #BB/I02333X/1
Pays : International
Organisme : Medical Research Council
ID : MR/M008886/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00015/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R011338/1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Stem Cells published by Wiley Periodicals, Inc. on behalf of AlphaMed Press 2019.

Références

Cell Stem Cell. 2016 Jun 2;18(6):769-81
pubmed: 27151457
Invest Ophthalmol Vis Sci. 1995 Feb;36(2):263-75
pubmed: 7843898
Stem Cells. 2015 Jan;33(1):79-90
pubmed: 25183393
Eye (Lond). 2018 May;32(5):946-971
pubmed: 29503449
J Lipid Res. 2016 Feb;57(2):258-64
pubmed: 26630912
Mol Ther. 2017 Mar 1;25(3):634-653
pubmed: 28143742
Hum Mol Genet. 2010 Dec 1;19(23):4545-59
pubmed: 20858907
Nature. 2017 May 4;545(7652):48-53
pubmed: 28445462
Nat Rev Immunol. 2018 Jan;18(1):35-45
pubmed: 28787399
Development. 2002 May;129(10):2435-46
pubmed: 11973275
Cell Rep. 2016 Nov 22;17(9):2460-2473
pubmed: 27880916
Nat Genet. 2004 Apr;36(4):351-60
pubmed: 14991054
Stem Cells. 2018 Mar;36(3):313-324
pubmed: 29230913
Cell Stem Cell. 2012 Jun 14;10(6):771-785
pubmed: 22704518
Cell. 1997 Nov 14;91(4):531-41
pubmed: 9390562
Nat Genet. 1999 Dec;23(4):466-70
pubmed: 10581037
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Nat Commun. 2017 Aug 16;8(1):271
pubmed: 28814713
Vis Neurosci. 2014 Sep;31(4-5):317-32
pubmed: 24847731
Sci Rep. 2018 Feb 5;8(1):2370
pubmed: 29402929
Sci Rep. 2017 Apr 10;7(1):766
pubmed: 28396597
Nat Methods. 2017 May;14(5):483-486
pubmed: 28346451
Prog Retin Eye Res. 2003 Sep;22(5):607-55
pubmed: 12892644
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Cell Res. 2017 Aug;27(8):967-988
pubmed: 28621329
Stem Cell Reports. 2018 Feb 13;10(2):406-421
pubmed: 29307580
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E81-90
pubmed: 26699487
Sci Rep. 2016 Mar 11;6:22867
pubmed: 26965927
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):776-787
pubmed: 29392326
Dev Cell. 2013 Jul 15;26(1):59-72
pubmed: 23867227
Stem Cells. 2015 Aug;33(8):2416-30
pubmed: 25827910
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):1101-6
pubmed: 23288902
J Lipid Res. 2010 Apr;51(4):685-700
pubmed: 19828910
PLoS One. 2012;7(5):e37926
pubmed: 22629470
Trends Mol Med. 2017 Jun;23(6):563-576
pubmed: 28501348
Science. 1974 Nov 1;186(4162):449-51
pubmed: 4369896
Stem Cells. 2016 Feb;34(2):311-21
pubmed: 26608863
Nature. 2006 Nov 9;444(7116):203-7
pubmed: 17093405
Nat Commun. 2015 Feb 19;6:6286
pubmed: 25695148
Nat Commun. 2016 Oct 04;7:13029
pubmed: 27701378
Curr Eye Res. 2011 Dec;36(12):1069-77
pubmed: 21978133
Development. 2019 Jan 29;146(2):
pubmed: 30696714
Biochem J. 2017 Mar 20;474(7):1205-1220
pubmed: 28202712
Nat Commun. 2014 Jun 10;5:4047
pubmed: 24915161
Stem Cells. 2011 Aug;29(8):1206-18
pubmed: 21678528
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3017-27
pubmed: 16799048
Nature. 1990 Oct 18;347(6294):677-80
pubmed: 1977087
Neurosci Res. 2017 Oct;123:1-7
pubmed: 28433627
Stem Cells. 2018 May;36(5):709-722
pubmed: 29327488
Curr Biol. 2015 Aug 17;25(16):2111-22
pubmed: 26234216
Stem Cell Reports. 2017 Dec 12;9(6):1898-1915
pubmed: 29153988
Stem Cell Reports. 2014 Apr 24;2(5):662-74
pubmed: 24936453
J Lipid Res. 2015 Jan;56(1):81-97
pubmed: 25293590
Stem Cell Reports. 2017 Sep 12;9(3):820-837
pubmed: 28844659
Clin Transl Med. 2017 Dec;6(1):15
pubmed: 28405930
Development. 2017 Oct 15;144(20):3698-3705
pubmed: 28870990
Oncotarget. 2017 May 16;8(32):53763-53779
pubmed: 28881849

Auteurs

Joseph Collin (J)

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

Darin Zerti (D)

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

Rachel Queen (R)

Genomics Core Facility, Newcastle University, Newcastle, United Kingdom.

Tiago Santos-Ferreira (T)

CRTD/Center for Regenerative Therapies Dresden, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.

Roman Bauer (R)

Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom.

Jonathan Coxhead (J)

Genomics Core Facility, Newcastle University, Newcastle, United Kingdom.

Rafiqul Hussain (R)

Genomics Core Facility, Newcastle University, Newcastle, United Kingdom.

David Steel (D)

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

Carla Mellough (C)

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

Marius Ader (M)

CRTD/Center for Regenerative Therapies Dresden, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.

Evelyne Sernagor (E)

Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom.

Lyle Armstrong (L)

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

Majlinda Lako (M)

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH